nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PTGR2—cardiovascular system—attention deficit hyperactivity disorder	0.0209	0.0409	CbGeAlD
Indomethacin—PTGDR2—cerebellum—attention deficit hyperactivity disorder	0.019	0.0372	CbGeAlD
Indomethacin—PTGR2—midbrain—attention deficit hyperactivity disorder	0.0163	0.0319	CbGeAlD
Indomethacin—PTGDR2—brain—attention deficit hyperactivity disorder	0.0155	0.0302	CbGeAlD
Indomethacin—GLO1—forebrain—attention deficit hyperactivity disorder	0.0153	0.0299	CbGeAlD
Indomethacin—PTGR2—nervous system—attention deficit hyperactivity disorder	0.0134	0.0262	CbGeAlD
Indomethacin—PTGR2—central nervous system—attention deficit hyperactivity disorder	0.0129	0.0253	CbGeAlD
Indomethacin—GLO1—cardiovascular system—attention deficit hyperactivity disorder	0.0129	0.0252	CbGeAlD
Indomethacin—PTGR2—cerebellum—attention deficit hyperactivity disorder	0.0126	0.0247	CbGeAlD
Indomethacin—PLA2G2A—cardiovascular system—attention deficit hyperactivity disorder	0.012	0.0235	CbGeAlD
Indomethacin—ABCC6—cardiovascular system—attention deficit hyperactivity disorder	0.0119	0.0232	CbGeAlD
Indomethacin—PPARA—cardiovascular system—attention deficit hyperactivity disorder	0.0112	0.0219	CbGeAlD
Indomethacin—PTGR2—brain—attention deficit hyperactivity disorder	0.0103	0.0201	CbGeAlD
Indomethacin—GLO1—midbrain—attention deficit hyperactivity disorder	0.0101	0.0197	CbGeAlD
Indomethacin—PLA2G2A—midbrain—attention deficit hyperactivity disorder	0.00938	0.0183	CbGeAlD
Indomethacin—CXCL8—midbrain—attention deficit hyperactivity disorder	0.00928	0.0181	CbGeAlD
Indomethacin—CES1—cardiovascular system—attention deficit hyperactivity disorder	0.00832	0.0163	CbGeAlD
Indomethacin—GLO1—nervous system—attention deficit hyperactivity disorder	0.00829	0.0162	CbGeAlD
Indomethacin—GLO1—central nervous system—attention deficit hyperactivity disorder	0.00798	0.0156	CbGeAlD
Indomethacin—GLO1—cerebellum—attention deficit hyperactivity disorder	0.0078	0.0153	CbGeAlD
Indomethacin—PLA2G2A—nervous system—attention deficit hyperactivity disorder	0.00771	0.0151	CbGeAlD
Indomethacin—PLA2G2A—central nervous system—attention deficit hyperactivity disorder	0.00742	0.0145	CbGeAlD
Indomethacin—PPARG—forebrain—attention deficit hyperactivity disorder	0.00729	0.0143	CbGeAlD
Indomethacin—AKR1C3—midbrain—attention deficit hyperactivity disorder	0.00728	0.0142	CbGeAlD
Indomethacin—PPARA—nervous system—attention deficit hyperactivity disorder	0.0072	0.0141	CbGeAlD
Indomethacin—CXCL8—cerebellum—attention deficit hyperactivity disorder	0.00718	0.014	CbGeAlD
Indomethacin—PPARA—central nervous system—attention deficit hyperactivity disorder	0.00693	0.0136	CbGeAlD
Indomethacin—SLC10A1—nervous system—attention deficit hyperactivity disorder	0.00692	0.0135	CbGeAlD
Indomethacin—SLCO1A2—forebrain—attention deficit hyperactivity disorder	0.00688	0.0135	CbGeAlD
Indomethacin—PPARA—cerebellum—attention deficit hyperactivity disorder	0.00678	0.0132	CbGeAlD
Indomethacin—SLC10A1—central nervous system—attention deficit hyperactivity disorder	0.00667	0.013	CbGeAlD
Indomethacin—ABCC4—forebrain—attention deficit hyperactivity disorder	0.00662	0.0129	CbGeAlD
Indomethacin—GLO1—brain—attention deficit hyperactivity disorder	0.00634	0.0124	CbGeAlD
Indomethacin—PPARG—cardiovascular system—attention deficit hyperactivity disorder	0.00617	0.0121	CbGeAlD
Indomethacin—PLA2G2A—brain—attention deficit hyperactivity disorder	0.00589	0.0115	CbGeAlD
Indomethacin—CXCL8—brain—attention deficit hyperactivity disorder	0.00583	0.0114	CbGeAlD
Indomethacin—AKR1C3—cerebellum—attention deficit hyperactivity disorder	0.00563	0.011	CbGeAlD
Indomethacin—PPARA—brain—attention deficit hyperactivity disorder	0.0055	0.0108	CbGeAlD
Indomethacin—CES1—nervous system—attention deficit hyperactivity disorder	0.00534	0.0104	CbGeAlD
Indomethacin—SLC10A1—brain—attention deficit hyperactivity disorder	0.00529	0.0103	CbGeAlD
Indomethacin—CES1—central nervous system—attention deficit hyperactivity disorder	0.00514	0.0101	CbGeAlD
Indomethacin—SLC22A7—brain—attention deficit hyperactivity disorder	0.00472	0.00922	CbGeAlD
Indomethacin—AKR1C3—brain—attention deficit hyperactivity disorder	0.00457	0.00894	CbGeAlD
Indomethacin—SLC22A6—brain—attention deficit hyperactivity disorder	0.00455	0.0089	CbGeAlD
Indomethacin—SLCO1A2—midbrain—attention deficit hyperactivity disorder	0.00454	0.00888	CbGeAlD
Indomethacin—ABCC3—nervous system—attention deficit hyperactivity disorder	0.00436	0.00851	CbGeAlD
Indomethacin—ABCC3—central nervous system—attention deficit hyperactivity disorder	0.00419	0.0082	CbGeAlD
Indomethacin—CES1—brain—attention deficit hyperactivity disorder	0.00408	0.00798	CbGeAlD
Indomethacin—PPARG—nervous system—attention deficit hyperactivity disorder	0.00396	0.00774	CbGeAlD
Indomethacin—PTGS1—forebrain—attention deficit hyperactivity disorder	0.0039	0.00762	CbGeAlD
Indomethacin—PPARG—central nervous system—attention deficit hyperactivity disorder	0.00381	0.00745	CbGeAlD
Indomethacin—SLCO1A2—nervous system—attention deficit hyperactivity disorder	0.00374	0.0073	CbGeAlD
Indomethacin—PTGS2—forebrain—attention deficit hyperactivity disorder	0.00373	0.00729	CbGeAlD
Indomethacin—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00361	0.00706	CbGeAlD
Indomethacin—SLCO1A2—central nervous system—attention deficit hyperactivity disorder	0.0036	0.00703	CbGeAlD
Indomethacin—ABCC4—nervous system—attention deficit hyperactivity disorder	0.0036	0.00703	CbGeAlD
Indomethacin—SLC22A8—nervous system—attention deficit hyperactivity disorder	0.00357	0.00697	CbGeAlD
Indomethacin—SLCO1A2—cerebellum—attention deficit hyperactivity disorder	0.00352	0.00687	CbGeAlD
Indomethacin—ABCC4—central nervous system—attention deficit hyperactivity disorder	0.00346	0.00677	CbGeAlD
Indomethacin—SLC22A8—central nervous system—attention deficit hyperactivity disorder	0.00343	0.00671	CbGeAlD
Indomethacin—ABCC3—brain—attention deficit hyperactivity disorder	0.00333	0.00651	CbGeAlD
Indomethacin—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.0033	0.00644	CbGeAlD
Indomethacin—PTGS2—cardiovascular system—attention deficit hyperactivity disorder	0.00315	0.00616	CbGeAlD
Indomethacin—PPARG—brain—attention deficit hyperactivity disorder	0.00303	0.00592	CbGeAlD
Indomethacin—ABCC1—cerebellum—attention deficit hyperactivity disorder	0.00288	0.00564	CbGeAlD
Indomethacin—SLCO1A2—brain—attention deficit hyperactivity disorder	0.00286	0.00558	CbGeAlD
Indomethacin—ALB—brain—attention deficit hyperactivity disorder	0.00284	0.00555	CbGeAlD
Indomethacin—ABCC4—brain—attention deficit hyperactivity disorder	0.00275	0.00537	CbGeAlD
Indomethacin—SLC22A8—brain—attention deficit hyperactivity disorder	0.00273	0.00533	CbGeAlD
Indomethacin—PTGS2—midbrain—attention deficit hyperactivity disorder	0.00246	0.00481	CbGeAlD
Indomethacin—ABCC1—brain—attention deficit hyperactivity disorder	0.00234	0.00458	CbGeAlD
Indomethacin—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00231	0.00451	CbGeAlD
Indomethacin—PTGS1—nervous system—attention deficit hyperactivity disorder	0.00212	0.00414	CbGeAlD
Indomethacin—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.00204	0.00398	CbGeAlD
Indomethacin—PTGS2—nervous system—attention deficit hyperactivity disorder	0.00202	0.00395	CbGeAlD
Indomethacin—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00195	0.00381	CbGeAlD
Indomethacin—PTGS2—central nervous system—attention deficit hyperactivity disorder	0.00195	0.00381	CbGeAlD
Indomethacin—PTGS2—cerebellum—attention deficit hyperactivity disorder	0.0019	0.00372	CbGeAlD
Indomethacin—PTGS1—brain—attention deficit hyperactivity disorder	0.00162	0.00316	CbGeAlD
Indomethacin—PTGS2—brain—attention deficit hyperactivity disorder	0.00155	0.00302	CbGeAlD
Indomethacin—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00152	0.00298	CbGeAlD
Indomethacin—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00125	0.00245	CbGeAlD
Indomethacin—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.0012	0.00236	CbGeAlD
Indomethacin—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00118	0.0023	CbGeAlD
Indomethacin—ABCB1—brain—attention deficit hyperactivity disorder	0.000957	0.00187	CbGeAlD
Indomethacin—SLC22A8—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000394	0.000807	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000386	0.000791	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000384	0.000787	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—SNAP25—attention deficit hyperactivity disorder	0.000384	0.000786	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000383	0.000784	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000383	0.000784	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000383	0.000784	CbGpPWpGaD
Indomethacin—ABCC4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000378	0.000774	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000377	0.000771	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000376	0.00077	CbGpPWpGaD
Indomethacin—PTGS2—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.000375	0.000767	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000374	0.000765	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000372	0.000761	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000369	0.000756	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000368	0.000753	CbGpPWpGaD
Indomethacin—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000366	0.00075	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000362	0.000741	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000359	0.000735	CbGpPWpGaD
Indomethacin—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000358	0.000732	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000356	0.000729	CbGpPWpGaD
Indomethacin—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000355	0.000727	CbGpPWpGaD
Indomethacin—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000353	0.000722	CbGpPWpGaD
Indomethacin—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00035	0.000717	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000349	0.000714	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000349	0.000714	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000348	0.000712	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000346	0.000709	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000343	0.000702	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000342	0.0007	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000342	0.0007	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000338	0.000691	CbGpPWpGaD
Indomethacin—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000337	0.000689	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000335	0.000686	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000334	0.000684	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000333	0.000683	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—COMT—attention deficit hyperactivity disorder	0.000333	0.000682	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000331	0.000677	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000331	0.000677	CbGpPWpGaD
Indomethacin—SLC22A6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000329	0.000674	CbGpPWpGaD
Indomethacin—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000326	0.000667	CbGpPWpGaD
Indomethacin—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000324	0.000663	CbGpPWpGaD
Indomethacin—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000322	0.000659	CbGpPWpGaD
Indomethacin—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000322	0.000658	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000322	0.000658	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000321	0.000657	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000319	0.000653	CbGpPWpGaD
Indomethacin—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000319	0.000653	CbGpPWpGaD
Indomethacin—ABCC1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000315	0.000645	CbGpPWpGaD
Indomethacin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000315	0.000644	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000314	0.000644	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000311	0.000637	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000311	0.000637	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000307	0.000629	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000306	0.000627	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0003	0.000614	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000299	0.000613	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000289	0.000592	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000285	0.000584	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000283	0.00058	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000281	0.000576	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STUB1—attention deficit hyperactivity disorder	0.00028	0.000573	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000279	0.000571	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000273	0.000559	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000269	0.00055	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000265	0.000543	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000264	0.000541	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000264	0.000541	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000264	0.000541	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000264	0.000541	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000261	0.000534	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00026	0.000533	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00026	0.000532	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00026	0.000532	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000256	0.000524	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000254	0.000519	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000253	0.000517	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00025	0.000512	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00025	0.000512	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000246	0.000503	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000244	0.000499	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000243	0.000496	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000242	0.000495	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000242	0.000495	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000242	0.000495	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000235	0.000482	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000235	0.00048	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00023	0.000471	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00023	0.000471	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000229	0.000468	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000228	0.000467	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000228	0.000466	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000226	0.000463	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00022	0.000451	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000215	0.00044	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000215	0.00044	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000215	0.00044	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000215	0.00044	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000212	0.000434	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000211	0.000433	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000211	0.000433	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—COMT—attention deficit hyperactivity disorder	0.000211	0.000433	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000211	0.000433	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000211	0.000433	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000211	0.000432	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00021	0.000431	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00021	0.000429	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000207	0.000424	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000207	0.000424	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000205	0.00042	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000204	0.000417	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000203	0.000416	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000202	0.000413	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000201	0.000412	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000201	0.000412	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000201	0.000412	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.0002	0.000409	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000199	0.000408	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000198	0.000405	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000197	0.000403	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000197	0.000403	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000196	0.000402	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000196	0.000402	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000194	0.000397	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000194	0.000396	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00019	0.000389	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000189	0.000388	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000186	0.00038	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000184	0.000377	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00018	0.000368	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000177	0.000362	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000175	0.000359	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000175	0.000358	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000175	0.000358	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000172	0.000353	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000172	0.000351	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000172	0.000351	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000171	0.00035	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000166	0.000339	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000165	0.000338	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000163	0.000335	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000163	0.000335	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000163	0.000334	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000163	0.000333	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00016	0.000328	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—COMT—attention deficit hyperactivity disorder	0.00016	0.000328	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—COMT—attention deficit hyperactivity disorder	0.00016	0.000328	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000159	0.000326	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000159	0.000325	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000159	0.000325	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000158	0.000323	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000157	0.000322	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000154	0.000316	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—COMT—attention deficit hyperactivity disorder	0.000151	0.00031	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00015	0.000308	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00015	0.000307	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00015	0.000307	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000146	0.000299	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000146	0.000298	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—EP300—attention deficit hyperactivity disorder	0.000143	0.000293	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000143	0.000292	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00014	0.000287	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000139	0.000285	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000139	0.000285	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000139	0.000285	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000138	0.000283	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000138	0.000282	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000137	0.00028	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000134	0.000275	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000133	0.000273	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000133	0.000273	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000133	0.000272	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.00013	0.000266	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—COMT—attention deficit hyperactivity disorder	0.00013	0.000266	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00013	0.000266	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000129	0.000264	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000129	0.000264	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000127	0.00026	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000125	0.000257	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000125	0.000256	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—EP300—attention deficit hyperactivity disorder	0.000125	0.000255	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000125	0.000255	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000122	0.000249	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000121	0.000247	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000119	0.000244	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000118	0.000242	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000115	0.000235	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000112	0.00023	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000112	0.00023	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000111	0.000227	CbGpPWpGaD
Indomethacin—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000111	0.000226	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000106	0.000217	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000106	0.000217	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000105	0.000216	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000104	0.000214	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000103	0.000211	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000102	0.000209	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000101	0.000207	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000101	0.000207	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	9.93e-05	0.000203	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	9.85e-05	0.000202	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.85e-05	0.000202	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	9.69e-05	0.000198	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.23e-05	0.000189	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	9.2e-05	0.000188	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.2e-05	0.000188	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—EP300—attention deficit hyperactivity disorder	9.06e-05	0.000185	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	9.05e-05	0.000185	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.01e-05	0.000184	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.99e-05	0.000184	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.74e-05	0.000179	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.56e-05	0.000175	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—COMT—attention deficit hyperactivity disorder	8.42e-05	0.000172	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.42e-05	0.000172	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MAOA—attention deficit hyperactivity disorder	8.36e-05	0.000171	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.11e-05	0.000166	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.07e-05	0.000165	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.88e-05	0.000161	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.68e-05	0.000157	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.5e-05	0.000153	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.36e-05	0.000151	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	7.2e-05	0.000148	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7e-05	0.000143	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.89e-05	0.000141	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—EP300—attention deficit hyperactivity disorder	6.87e-05	0.000141	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—EP300—attention deficit hyperactivity disorder	6.87e-05	0.000141	CbGpPWpGaD
Indomethacin—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	6.81e-05	0.000139	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	6.76e-05	0.000138	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.56e-05	0.000134	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—EP300—attention deficit hyperactivity disorder	6.49e-05	0.000133	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EP300—attention deficit hyperactivity disorder	6.42e-05	0.000132	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	6.11e-05	0.000125	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	6.07e-05	0.000124	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—EP300—attention deficit hyperactivity disorder	5.98e-05	0.000122	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	5.97e-05	0.000122	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.93e-05	0.000121	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.89e-05	0.000121	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—EP300—attention deficit hyperactivity disorder	5.58e-05	0.000114	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—EP300—attention deficit hyperactivity disorder	5.58e-05	0.000114	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	5.58e-05	0.000114	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	5.54e-05	0.000113	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—EP300—attention deficit hyperactivity disorder	5.38e-05	0.00011	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.37e-05	0.00011	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—EP300—attention deficit hyperactivity disorder	5.11e-05	0.000105	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	4.55e-05	9.31e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EP300—attention deficit hyperactivity disorder	4.31e-05	8.83e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—EP300—attention deficit hyperactivity disorder	3.61e-05	7.39e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	2.92e-05	5.98e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.62e-05	5.37e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.56e-05	5.24e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.39e-05	4.9e-05	CbGpPWpGaD
